Combining mass media and the internet to screen individuals at risk for hepatitis C Freke Zuure Online Research and Prevention unit Public Health Service.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

Core Concepts for Hepatitis Education Authors: n Lisa K. Gilbert, PhD n Kathy Ford, MSSW n David Bergmire-Sweat, MPH Funded by the Centers for Disease.
Case management for multimorbid patients Nathalie Versnel, MSc. François Schellevis, MD, PhD Giel Nijpels, MD, PhD Caroline Baan, PhD.
Rik Koekenbier, Fennema H, Leent van E, Zuilhof W, Veen van E, Davidovich U Online Research and Prevention unit Amsterdam Public Health Service Research.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
1 TB/HIV Project in the Philippines Yumiko Yanase.
Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.
Sexual Health & the Internet The role of Internet interventions- current achievements and potential Udi Davidovich, PhD ORP – Online Research & Prevention.
RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Need for vaccination for vaccine preventable hepatitis in methadone maintenance treatment Randy Seewald, MD 1,2,3, Eli Kamara, BS 2, Ruy Tio, DO 1,2, Rashiah.
Prevalence of hepatitis B and C viruses among human immunodeficiency virus infected children in Northern Nigeria. Pennap GRI, Yahuza, AJ and Abdulkarim,
HEPATITIS C Kimberly Klatt. CHARACTERISTICS  Virus  Enveloped  Single-stranded RNA virus  High mutation rate  6 different genotypes  Most cases.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
PERINATAL HEPATITIS B PREVENTION Kristin Gerard, MPH Epidemiologist, Immunization Program Connecticut Department of Public Health.
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
Abstract MOAB0301 Hepatitis C Care Cascade for People Living With HIV in the Country of Georgia Nikoloz Chkhartishvili1, A. Abutidze1, N. Bolokadze1, O.
1University of Kentucky, Lexington, Kentucky
National Hepatitis C Database
Contact: Kamran Rahmatnejad, MD
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
The Association of Exposure to Adverse
No conflicts of interest to declare.
TB- HIV Collaborative activities in Romania- may 2006 status
NCD in Bulgaria Assoc. Prof. Plamen Dimitrov, MD, PhD
Disparities in process and outcome measures among adults with persistent asthma David M. Mosen, PhD, MPH; Michael Schatz, MD, MS; Rachel Gold, PhD; Winston.
Government of Swaziland
PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG FEDERAL
Collaborations/Coordination
Massachusetts Department of Public Health
DEVELOPMENT OF A SEXUALLY TRANSMITTED INFECTION ONLINE COURSE
Getting to the second 90 in adolescent HIV: What is needed
Presenter: Corina de Jong PhD Department of General Practice,
Cascade of care for persons newly diagnosed
Believed discrimination occurred because of their:
Results of Youth Satisfaction Survey Race distribution of patients
Results of the STRUTI project
We have provided patients with diagnosis and
Illustrating HIV/AIDS in the United States
Comparison of the study findings: Male & female
Integrating Hepatitis C Treatment in Primary Care
Integrating Hepatitis C Treatment in Primary Care
No one gets left behind: Addressing the hidden burden of hepatitis C related advanced liver disease in PWID in the community John S Lambert, MD, PhD.
A qualitative assessment of factors impacting adoption and implementation of USPSTF age-based hepatitis C virus screening recommendations Amy B. Jessop,
C-SCOPE: Survey on the Management of HCV in addiction clinics treating Patients on Opiate Agonist Therapies: a global perspective July 2017.
JAMA Ophthalmology Journal Club Slides: Validity of the Age-Related Eye Disease Study Grading Scale Vitale S, Clemons TE, Agrón E, et al; Age-Related Eye.
Illustrating HIV/AIDS in the United States
Subjects and Methods Introduction Results
Illustrating HIV/AIDS in the United States
John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.
Illustrating HIV/AIDS in the United States
Illustrating HIV/AIDS in the United States
Illustrating HIV/AIDS in the United States
Prevalence of vaccine type infections in vaccinated and non-vaccinated young women: HPV- IMPACT, a self-sampling study.   Jeannot E1,2, Viviano M3, de.
Mirela Anghelina, M.D., M.P.H.
Module 2: HCV transmission and risk prevention
Progress in Facilitating National HCV Prevention
Smoking Cessation Smoke Signals.
Epidemiology of Tuberculosis in Hong Kong
Integrating Hepatitis C care for at-risk groups: Findings from a Multi-centre Observational Study in Primary and Community Care Nic An Riogh E1, Swan D¹,
Illustrating HIV/AIDS in the United States
Professor Jack Lambert
Akiko C. Kimura, MD Jeffrey Higa, MPH Christine Nguyen, MPH
Knowledge of HIV Status in Kenya
 FGMToolkit.gwu.edu A living virtual toolkit for the care and prevention of FGM/C for women and health care providers August 28, 2019.
Presentation transcript:

Combining mass media and the internet to screen individuals at risk for hepatitis C Freke Zuure Online Research and Prevention unit Public Health Service of Amsterdam

GOR 2009 Hepatitis C virus (HCV) infection  Transmission mainly through blood-blood contact  No vaccine available  ± 180 million infections worldwide  Low prevalence in many Western countries  Asymptomatic at first  In years HCV can lead to severe liver problems  Improved treatment options available  Problem: multi-faceted risk groups, hidden in the general population

GOR 2009 Hepatitis C Internet Project (HIP) Overall aim: To evaluate whether a hidden population of HCV-infected individuals can be identified through a public media campaign alongside an internet risk assessment and low-threshold blood screening procedure

GOR 2009 HIP details  Pilot project in the Netherlands  Amsterdam and South Limburg  Aim: to test ~6,000 individuals at risk for HCV infection between April 2007 and December 2008

GOR Public, regional media campaign HIP strategy

GOR Public, regional media campaign 2.Tailored HCV risk assessment questionnaire at HIP strategy Questionnaire was evaluated before its online use in a study among liver patients with known HCV status (before HIP): Sensitivity: 84.6% Specificity: 63.8%

GOR Public, regional media campaign 2.Tailored HCV risk assessment questionnaire at 3.Free and anonymous blood test HIP strategy

GOR Open media campaign 2.Tailored HCV risk assessment questionnaire at 3.Free and anonymous blood test 4.Free and anonymous confirmation test at the Public Health Service 5.Direct referral to a specialist at the hospital HIP strategy

GOR 2009 Additional online services 1.Free and/or SMS reminder for blood testing 2.Free and/or SMS alert when the test’s result could be obtained online Additional data collection Online questionnaire on usability and acceptability of the screening procedure

GOR 2009 Results

GOR 2009

Evaluation study on perceived usability and acceptability  How do participants experience the risk screening tool in terms of usability and acceptability?

GOR 2009 Method Online questionnaire, offered to all participants after receiving the result of the risk assessment questionnaire

GOR 2009 Measures (1) Usability: ‘ease of use’ (n=4, α=.81) and ‘usefulness’ (n=5, α=.89) “How comprehensible are the risk test questions to you?” Acceptability of online risk test (n=4, α=.87) and virtual paper&pencil risk test (n=4, α=.92) “What did you think of determining your risk on the Internet? unpleasant ***** pleasant”

GOR 2009 Measures (2) Internet skills (n=4, α=.83) “How familiar are you with using Internet questionnaires?“ Outcome efficacy (n=3, α=.71) “How important do you think it is for you to know whether you are infected with hepatitis C?”

GOR 2009 U&A study population

GOR 2009 U&A study population  N= 2,154  Median age: 44 years (IQR 31 – 55 years)  42.7% male  Education –Low11.5% –Low medium32.9% –Medium high46.3% –High9.3%

GOR 2009 Results (n=2,154) Mean score 5 point scale Std. deviation Internet skills Usability: online risk questionnaire Usability: online risk questionnaire result Acceptability: online risk assessment Acceptability: paper risk assessment Outcome efficacy4.80.4

GOR 2009 Results How would you prefer to complete the hepatitis C risk test? (n=2,154) on paper2.5% on the internet82.5% no preference15.1% Do you intend to follow the risk test advice? (n=259) IntentionN (%) Testing advice compliance 1 Certainly not2 (0.8%)1 / 2 (50%) 21 (0.4%)0 (0%) 310 (3.9%)2 / 10 (20%) 426 (10.0%)7 / 26 (26.9%) 5 Certainly220 (84.9%)130 / 220 (59.1%) Mean score 4,8

GOR 2009 U&A study limitation  Females, older aged, and testing-advice-adherent participants were significantly more willing to participate in the usability & acceptability study

GOR 2009 Conclusions  Testing procedure using the internet works well  Blood test advice uptake (28%) is much higher compared to similar projects  Usability and acceptability as perceived by participants is high  Risk assessment questionnaire selects high risk groups as the HCV prevalence among testers (3.5%) is 9-35 times the estimated prevalence among the Dutch population  Website attracted less persons at risk of HCV than expected, and therefore the number of identified HCV infected individuals is low

GOR 2009 Acknowledgements  Public Health Service of Amsterdam:Maria Prins, PhD Udi Davidovich, PhD Anneke van den Hoek, MD, PhD  South Limburg Public Health Service:Christian Hoebe, MD, PhD Hans Frantzen Natacha Gelissen  National Hepatitis Center:Paula van Leeuwen, MSc  Academic Medical Center, Amsterdam:Christine Weegink, MD, PhD prof. Peter Jansen, MD  Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven:prof. Roel Coutinho, MD  School of Psychology, University of Maastricht:prof. Gerjo Kok  And all other participants and co-workers of the departments This project is funded by Roche Netherlands provided an unrestricted grant for broadcasting of the television commercial Schering-Plough provided an unrestricted grant for the translation of